(Reuters) – Germany gave itself new powers to veto hostile foreign takeover bids for healthcare companies on Wednesday, a measure designed to ensure a continuous supply of essential products during the coronavirus crisis.

The regulation, approved by the cabinet, will allow the government to block takeovers of makers of vaccines, precursor chemicals, medicines, protective equipment or medical machinery such as ventilators.

The measure comes after the early stages of the coronavirus saw a worldwide run on materials believed crucial to combat COVID-19 – the respiratory disease caused by the new virus – including reported attempts by the United States government to buy Curevac, a pharmaceuticals start-up that was working to develop a vaccine against the disease.

In future, the government will be allowed to examine the security implications of a bid from outside the European Union as soon as the buyer holds more than 10% of the healthcare company’s shares. Now, the threshold is 25%.

Media reports that the United States tried to gain access to unlisted CureVac or the vaccine it was working on prompted German cabinet members to voice support for keeping the biotech firm German. CureVac has denied having received U.S. offers.

The boss of Germany’s BioNTech (BNTX.O), also a contestant in the race to find a vaccine, told a newspaper in April that a takeover was out of the question and that the company had received unspecified approaches.

The move echoes earlier moves by Berlin to protect the high-tech companies that have made its economy an exporting powerhouse from takeover bids by ambitious, fast-growing Chinese rivals.

Some in the industry were critical of the latest move, arguing that it sends the wrong signal in the midst of a crisis.

“During a crisis it is more important than ever to stand for open markets,” the Federation of German Industry’s board member Stefan Mair said in a statement.

Reporting by Thomas Escritt, Christian Kraemer and Andreas Rinke; editing by John Stonestreet and Alex Richardson

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Dada Group sees net revenue soar in Q2

Dada Group, China’s leading local on-demand delivery and retail platform reported its net revenues reached 1.323 billion yuan ($187.3 million) in the second quarter of 2020, an increase of 93.1 percent year-on-year, while the orders delivered through Dada Now for…

U.S. House panel calls on Amazon’s Bezos to testify on third-party sellers

WASHINGTON (Reuters) – The U.S. House of Representatives Judiciary Committee on Friday called on Amazon.com < AMZN.O> founder Jeff Bezos to testify to the panel about allegations that the online retailer uses data from its own third-party sellers to create…

China’s job positions for recruitment edges down in Q1: report

BEIJING – Affected by the COVID-19 outbreak, China saw its job positions for employment drop 27 percent year-on-year in the first quarter of 2020, a report showed. Recruitment of sectors including purchasing and trading, advertising and exhibition and automobile sales…

‘Friendly’ China-Germany rivalry in the race for better solar panels

A year after Ursula von der Leyen declared her ambition of making Europe the world’s first carbon-neutral continent, officials and business leaders have discussed whether the coronavirus pandemic would hinder – or help – that target. The European Commission president…